| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d4ad61d0af1fd483d31d1c5df9b9b76 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2317 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0633
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5073 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
| filingDate |
2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a92d927369598b55e88aefbfffeb3f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f97ef92a8d3ef0548714eeb2039fd7a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59b63549c5e1f728e99994f6af847589
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6e2fefe80066cb67f019c906e7b6d5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3b5eab3126aa603c9989ff0c8e07a42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_534f118d66dbd7b5170c2f61098d8870
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fdc16f1d2858d9f7acac1b61690bbde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01bfc873494289885b921bc50a6c5048 |
| publicationDate |
2021-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210121365-A |
| titleOfInvention |
Sjogren's disease salivary gland organoid model evaluation platform |
| abstract |
The present invention relates to an evaluation platform for the Sjogren's disease salivary gland organoid model. The Sjogren's syndrome model produced as the Sjogren's disease salivary gland organoid model evaluation platform of the present invention was to overcome the limitation that the incidence rate could not be arbitrarily controlled, and to supplement the point that there was no model that could not confirm the patient's immunopathies. Therefore, the Sjogren's syndrome model of the present invention can be used not only for screening of therapeutic agents for Sjogren's syndrome, but also for drug evaluation of individual Sjogren's syndrome patients, as well as for understanding pathological mechanisms and developing a customized disease diagnosis and control system, which is useful in related fields. can be used |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102547900-B1 |
| priorityDate |
2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |